Retatrutide 40mg
Triple GLP-1 / GIP / Glucagon receptor agonist
≥99.0%
Third-Party
COA
Also available in 10mg · 20mg · 30mg · 50mg — compare all sizes
Complete your research kit
Also searched as: Reta, R3ta, Reta peptide, LY3437943
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
Retatrutide 40mg is a research-grade peptide supplied for laboratory investigation into multi-receptor metabolic signalling. Retatrutide is a single synthetic peptide designed to interact with three receptor systems: the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). The 40mg format provides researchers with a higher-quantity option for controlled experimental work. It is intended strictly for laboratory and scientific research and should be handled according to appropriate research protocols.
What Is Retatrutide 40mg?
Retatrutide is commonly described in scientific literature as a triple receptor agonist because of its activity at GLP-1, GIP and glucagon receptors. These receptor pathways are involved in several aspects of metabolic and endocrine signalling.
Unlike single-receptor compounds, retatrutide provides researchers with an opportunity to investigate how simultaneous activation of three related signalling pathways may influence experimental metabolic models. Its multi-agonist structure has therefore attracted interest in research examining energy regulation, glucose-related pathways and metabolic signalling.
Key Research Areas
Retatrutide research has primarily examined mechanisms associated with:
Findings from experimental or clinical research should not be interpreted as establishing this research material as suitable for personal or therapeutic use.
Why Researchers Study Retatrutide 40mg
The distinguishing feature of retatrutide is its triple-agonist mechanism. GLP-1 and GIP receptors are associated with incretin signalling, while glucagon-receptor activity introduces another pathway involved in metabolic regulation and energy balance.
Researchers are particularly interested in understanding how these receptor systems behave when investigated through a single multi-receptor compound. Retatrutide 40mg may therefore be useful for laboratory projects requiring a larger quantity of the same research material.
Key Research Areas at a Glance
Retatrutide 40mg in Australia
Researchers looking for Retatrutide 40mg Australia should check the current product listing for stock status, price, analytical specifications and available CoA documentation before ordering. Domestic shipping details should likewise be confirmed at checkout or through the supplier’s current delivery information.
Retatrutide 40mg is supplied as a research material and must not be represented as an approved medicine or consumer therapeutic product.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Researchers should verify the analytical specifications supplied with the individual Retatrutide 40mg batch before beginning experimental work. Where a batch-specific Certificate of Analysis (CoA) is provided, it should be reviewed for information such as identity, measured purity and applicable analytical testing.
Analytical purity or identity testing confirms characteristics of the research material; it does not establish clinical safety, therapeutic effectiveness or suitability for human use.
Storage & Handling
Storage and Laboratory Handling
Retatrutide 40mg should be stored and handled according to the conditions stated in the supplier’s batch documentation. Appropriate laboratory procedures should be used to minimise contamination and unnecessary environmental exposure.
After reconstitution, researchers should follow validated laboratory protocols or batch-specific documentation rather than assuming an unsupported stability period, temperature or storage duration.
Reconstitution calculator: Retatrutide 40mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
Retatrutide 40mg: Frequently Asked Questions
It is a 40mg research peptide format designed for laboratory investigation of GLP-1, GIP and glucagon receptor pathways.
It demonstrates agonist activity across GLP-1R, GIPR and GCGR, allowing researchers to examine multiple metabolic signalling pathways.
The term refers to its activity at three distinct receptor systems: GLP-1, GIP and glucagon receptors.
Research has examined metabolic signalling, glucose-related mechanisms, energy regulation and body-composition pathways.
Researchers should consult the analytical documentation accompanying the specific batch for verified purity information.
Where provided, the batch-specific CoA should contain relevant analytical information for that particular research batch.
Follow the verified storage conditions supplied with the product or its batch documentation.
Availability, current price, stock status and Australian shipping should be confirmed through the supplier's current product listing.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
Retatrutide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.